Du W, Gu M, Hu M, Pinchi P, Chen W, Ryan M
Cell Rep. 2021; 37(3):109848.
PMID: 34686351
PMC: 8559338.
DOI: 10.1016/j.celrep.2021.109848.
Solier S, Pommier Y
Cancer Res. 2010; 71(3):906-13.
PMID: 21148072
PMC: 3032822.
DOI: 10.1158/0008-5472.CAN-10-3297.
Mukwena N, Al-Rubeai M
Cytotechnology. 2008; 46(2-3):79-95.
PMID: 19003264
PMC: 3449713.
DOI: 10.1007/s10616-005-8306-7.
Zang G, Zhou X, Yu H, Xie Q, Zhao G, Wang B
World J Gastroenterol. 2002; 6(5):688-692.
PMID: 11819675
PMC: 4688844.
DOI: 10.3748/wjg.v6.i5.688.
Devireddy L, Jones C
J Virol. 1999; 73(5):3778-88.
PMID: 10196272
PMC: 104155.
DOI: 10.1128/JVI.73.5.3778-3788.1999.
Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells.
Hung W, Chang H, Chuang L
Biochem J. 1999; 338 ( Pt 1):161-6.
PMID: 9931312
PMC: 1220038.
Caspases: the executioners of apoptosis.
Cohen G
Biochem J. 1997; 326 ( Pt 1):1-16.
PMID: 9337844
PMC: 1218630.
DOI: 10.1042/bj3260001.
Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death.
Miller T, Moulder K, Knudson C, Creedon D, Deshmukh M, Korsmeyer S
J Cell Biol. 1997; 139(1):205-17.
PMID: 9314540
PMC: 2139809.
DOI: 10.1083/jcb.139.1.205.
Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells.
MacFarlane M, Cain K, Sun X, Alnemri E, Cohen G
J Cell Biol. 1997; 137(2):469-79.
PMID: 9128256
PMC: 2139780.
DOI: 10.1083/jcb.137.2.469.
Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.
Hara H, Friedlander R, Gagliardini V, Ayata C, Fink K, Huang Z
Proc Natl Acad Sci U S A. 1997; 94(5):2007-12.
PMID: 9050895
PMC: 20033.
DOI: 10.1073/pnas.94.5.2007.
Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli.
Sarin A, Wu M, Henkart P
J Exp Med. 1996; 184(6):2445-50.
PMID: 8976202
PMC: 2196389.
DOI: 10.1084/jem.184.6.2445.
Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.
Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P
J Exp Med. 1996; 184(5):2067-72.
PMID: 8920897
PMC: 2192862.
DOI: 10.1084/jem.184.5.2067.
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
Susin S, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A
J Exp Med. 1996; 184(4):1331-41.
PMID: 8879205
PMC: 2192812.
DOI: 10.1084/jem.184.4.1331.
Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.
Slee E, Zhu H, Chow S, MacFarlane M, Nicholson D, Cohen G
Biochem J. 1996; 315 ( Pt 1):21-4.
PMID: 8670109
PMC: 1217173.
DOI: 10.1042/bj3150021.
Constitutive expression of the machinery for programmed cell death.
Weil M, Jacobson M, Coles H, Davies T, Gardner R, Raff K
J Cell Biol. 1996; 133(5):1053-9.
PMID: 8655578
PMC: 2120862.
DOI: 10.1083/jcb.133.5.1053.
Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.
Jacobsen M, Weil M, Raff M
J Cell Biol. 1996; 133(5):1041-51.
PMID: 8655577
PMC: 2120856.
DOI: 10.1083/jcb.133.5.1041.